furosemide has been researched along with Skin Neoplasms in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Skin Neoplasms: Tumors or cancer of the SKIN.
Excerpt | Relevance | Reference |
---|---|---|
" To our knowledge, we report the first case using an MTX serum assay as a surrogate for PDX concentrations to avoid a potential drug-drug interaction with pralatrexate." | 1.43 | Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions. ( Gilreath, JA; Halwani, AS; McPherson, JP; Sedillo, C; Vrontikis, A, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Tchernev, G | 1 |
McPherson, JP | 1 |
Vrontikis, A | 1 |
Sedillo, C | 1 |
Halwani, AS | 1 |
Gilreath, JA | 1 |
Sultana, S | 1 |
Saleem, M | 1 |
3 other studies available for furosemide and Skin Neoplasms
Article | Year |
---|---|
NITROSAMINES IN COMMONLY PRESCRIBED ANTIHYPERTENSIVES AND THE (UN)CONTROLLED DRUG-INDUCED SKIN CANCER: SIMULTANEOUS DEVELOPMENT OF CUTANEOUS MELANOMA AND MULTIPLE BCC AFTER CONCOMITANT ADMINISTRATION OF BISOPROLOL AND FUROSEMIDE.
Topics: Antihypertensive Agents; Bisoprolol; Carcinogens; Furosemide; Humans; Melanoma; Melanoma, Cutaneous | 2023 |
Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.
Topics: Aged; Aminopterin; Drug Interactions; Drug Monitoring; Folic Acid Antagonists; Furosemide; Humans; I | 2016 |
Salix caprea inhibits skin carcinogenesis in murine skin: inhibition of oxidative stress, ornithine decarboxylase activity and DNA synthesis.
Topics: Administration, Cutaneous; Animals; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Femal | 2004 |